Pharmaceutical 5111 articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

FDA investigating deaths, illnesses possibly related to dietary supplement

Blue pills

The Food and Drug Administration (FDA) is investigating two fatalities and reports of two children with elevated levels of lead who may have consumed DHZC-2 dietary supplements manufactured by Ton Shen/Life Rising. The agency is also investigating other products made by the company for the presence of lead and other hazardous materials. The FDA tested product samples at the Ton Shen Health/Life Rising retail location in the Chicago metropolitan area in response to an adverse event report. The agency’s analysis confirmed that samples contained 56 times the amount of lead above that which would pose a health risk for children, ... Read More

If there is confusion about talc, who’s to blame?


Johnson & Johnson’s attorneys recently asserted that the plaintiffs’ lawyers “have deliberately created confusion about the science of talc at trial.” Jere L. Beasley, principal and founder of Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., whose trial team represented two plaintiffs in recent trials linking talcum powder to ovarian cancer, issued a statement refuting J&J’s claim, and, in fact, saying just the opposite is true. “It is the height of irony that Johnson & Johnson would claim that our trial team are the ones trying to create confusion surrounding the scientific evidence linking use of talcum powder for feminine hygiene to ovarian ... Read More

Cook Medical’s initial attempts at settling IVC Filter litigation Fail

IVC filter

Hundreds of people who have filed legal claims alleging they have been injured by failed inferior vena cava (IVC) filters have been considering Cook Medical’s talks of settlements. Howevre, U.S. Magistrate Judge Tim Baker and attorneys for both the medical device manufacturer and patients were unable to find common ground to reach a settlement. The meeting ended “without further order.” If the negotiations regarding the settlements fail, then the lawsuits filed by the patients claiming injury related to the IVC filters will go to trial. As of Aug. 15, the number of federal lawsuits in the Multi-District Litigation (MDL) against Cook Medical ... Read More

Metal-on-Metal Hips Marketed as ‘Better’ Despite Lack of Long-Term Data to Prove It

artificial hip

One of the most successful medical advancements of  the 20th century is the total hip replacement. In 2010 alone, more than 300,000 hip procedures were performed in the U.S. Many materials have been used in hip prosthetics, and metal-on-metal surfaces have been used as early as 1948. Because the metal-on-plastic models have shown to have higher revision rates for younger, more active patients, there has been a push toward reviving metal-on-metal hip implant designs. The metal-on-metal hips showed positive results during early short-term clinical studies. Because of this, orthopedic surgeons readily accepted this modernized version of an old prosthetic and recommended ... Read More

FDA may be making same deadly mistake it made approving power morcellators


Philadelphia-area doctors and husband-and-wife advocates Hoosman Noorchashm, M.D., Ph.D., and Amy J. Reed, M.D., Ph.D., published an editorial in The Inquirer Daily News warning that the Food and Drug Administration (FDA), in approving a new device, may be repeating the same deadly mistake it made when it approved the use of power morellation for hysterectomies and myomectomies. Power morcellators are surgical tools fitted with tube-like blades that shred uterine growths or entire uteruses within the abdomen and remove the tissue through a small incision in the belly. The procedure has been preferred in recent years to open surgery because it ... Read More

Women who claim they were injured by Essure fighting for their day in court


Becky Beesley struggles not to cry when she thinks back on the day in 2012 that she decided to get the Essure permanent birth control. “Immediately my body rejected the procedure,” she told ABC 15 News. “My leg started to tremor and I threw up a couple of times.” Within a few months, serious health issues began to emerge. “I felt like there were little gremlins…that were just trying to claw their way out.” She says the pain became so excruciating, she had to quit her teaching job. Her doctor finally removed the implant, but the pain persisted. Beesley saw ... Read More

Pfizer shifts focus to consumers after planned merger tanks

Viagra single pack

Pfizer is under fire legally with a multidistrict litigation (MDL) underway against its blockbuster drug Viagra, which has been linked to an increased risk of melanoma, the most deadly form of skin cancer. Men suing the company claim Pfizer failed to properly test the drug before releasing it to market, defective design, fraudulent misrepresentation and negligence to warn patients of the drug’s risks. One plaintiff alleges, according to the Madison County Record, that “Pfizer designed, manufactured, distributed and sold the unsafe drug, Viagra, intentionally concealed or misrepresented the risks, dangers and defects of taking the drug and failed to conduct adequate ... Read More

First four lawsuits set the stage for Xarelto bleeding events litigation


Joseph Boudreaux was prescribed the blood thinner Xarelto, but a month later he began bleeding internally so badly that he was hospitalized and required several blood transfusions. Joseph Orr’s wife used Xarelto for about a month before she died from a brain hemorrhage. Dora Mingo took Xarelto after developing blood clots, but had to discontinue treatment after she began bleeding in her gastrointestinal tract. William Henry died from a gastrointestinal bleed after taking Xarelto to prevent strokes associated with his heart condition, atrial fibrillation. These are the first four cases set to go to trial among more than 7,200 in a ... Read More

TBIs early in life linked to psychiatric problems, premature death

skull xray

Children and young adults who suffer even a mild head trauma are more likely to have to die early and have problems functioning as adults, according to a study conducted by researchers with the University of Oxford in England. The study compared 100,000 Swedes who had suffered a traumatic brain injury (TBI) before the age of 25 with their siblings, who had not suffered a TBI. Researchers found that those with head injuries were more likely to have psychiatric problems later in life and suffer a premature death. The effects of a TBI were more prominent in those who were older ... Read More

FDA warns of problems with low-rate infusion with programmable syringe pumps


Using programmable syringe pumps to infuse therapies at low rates may result in an inconsistent rate of delivery, which can lead to serious clinical consequences, including delay of therapy, over-infusion, or under-infusion, the Food and Drug Administration (FDA) warned health care professionals in a Safety Alert. Reports of serious adverse events such as abnormal or unstable blood pressure, anxiety from loss of sedation, and increased pain indicators in critically ill infants have been associated with this lack of flow continuity. Programmable syringe pumps deliver solutions such as fluids, medications, or blood products to patients. They are capable of delivering at low infusion ... Read More